Paul Holtzheimer
CE/CME Credit
January 16, 2020
Paul Holtzheimer, MD

Deep brain stimulation (DBS) is emerging as a potential intervention for patients with highly treatment-resistant depression (TRD). Early, open-label studies supported the safety and potential efficacy of DBS for TRD but later randomized, controlled trials have yielded mixed results.

Presentation Type